# US 2013/0096011 A1 · Detecting and classifying copy number variation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0096011 A1
- Document ID: US20130096011A1
- Status: Published application
- Kind: A1
- Application number: 13/600,043
- Filed: 2012-08-30
- Published: 2013-04-18
- Earliest claimed: 2010-01-19
- Assignees: Verinata Health, Inc.
- Inventors: Richard P. Rava; Anupama Srinivasan
- Web page: https://patentgrep.com/patent/US20130096011A1

## CPC

- G16B 20/10: Ploidy or copy number detection
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6869: Methods for sequencing
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 30/10: Sequence alignment; Homology search
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 2537/16: Assays for determining copy number or wherein the copy number is of special importance
- C12Q 2600/106: Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.

## Claims

### Claim 1

A method for classifying a copy number variation in a fetal genome, the method comprising:
(a) receiving sequence reads from fetal and maternal nucleic acids in a maternal test sample, wherein the sequence reads are provided in an electronic format;
(b) aligning the sequence reads to one or more bins from a reference sequence using a computing apparatus and thereby providing sequence tags corresponding to the sequence reads;
(c) computationally identifying a number of those sequence tags that are from one or more bins by using the computing apparatus and determining that a first bin of interest in the fetus harbors a copy number variation;
(d) calculating a first fetal fraction value by a first method that does not use information from the tags from the first bin of interest;
(e) calculating a second fetal fraction value by a second method that uses information from the tags from the first bin of interest; and
(f) comparing the first fetal fraction value and the second fetal fraction value and using the comparison to classify the copy number variation of the first bin of interest.

### Claim 2 (depends on 1)

The method of claim 1, wherein the comparing the first fetal fraction value and the second fetal fraction value comprises determining whether the two fetal fraction values are approximately equal.

### Claim 3 (depends on 2)

The method of claim 2, further comprising determining that the two fetal fraction values are approximately equal, and thereby determining that a ploidy assumption implicit in the second method is true.

### Claim 4 (depends on 3)

The method of claim 3, wherein the ploidy assumption implicit in the second method is that the first bin of interest has a complete aneuploidy.

### Claim 5 (depends on 2)

The method of claim 2, wherein comparing the first fetal fraction value and the second fetal fraction value indicates that the two fetal fraction values are not approximately equal, and further comprising analyzing the tag information for the first bin of interest to determine whether (i) the first bin of interest harbors a partial aneuploidy, or (ii) the fetus is a mosaic.

### Claim 6 (depends on 5)

The method of claim 5, wherein analyzing the tag information for the first bin of interest comprises:
dividing the sequence for the first bin of interest into a plurality of sub-bins;
determining whether any of said sub-bins contains significantly more or significantly less nucleic acid than one or more other sub-bins; and
if any of said portions contain significantly more or significantly less nucleic acid than one or more other sub-bins, determining that the first bin of interest harbors a partial aneuploidy.

### Claim 7 (depends on 6)

The method of claim 6, further comprising determining that a sub-bin of the first bin of interest containing significantly more or significantly less nucleic acid than one or more other portions harbors the partial aneuploidy.

### Claim 8 (depends on 5)

The method of claim 5, wherein analyzing the tag information for the first bin of interest comprises:
dividing the sequence for the first bin of interest into a plurality of sub-bins;
determining whether any of said sub-bins contains significantly more or significantly less nucleic acid than one or more other sub-bins; and
if none of said sub-bins contain significantly more or significantly less nucleic acid than one or more other sub-bins, determining that the fetus is a mosaic.

### Claim 9 (depends on 1)

The method of claim 1, wherein if the first fetal fraction value is not approximately equal to the second fetal fraction value,
(i) determining whether the copy number variation results from a partial aneuploidy or a mosaic; and
(ii) if the copy number variation results from a partial aneuploidy, determining the locus of the partial aneuploidy on the first bin of interest.

### Claim 10 (depends on 9)

The method of claim 9, wherein determining the locus of the partial aneuploidy on the first bin of interest comprises categorizing the sequence tags for the first bin of interest into sub-bins of blocks of nucleic acids in the first bin of interest; and counting the mapped tags in each sub-bin.

### Claim 11 (depends on 1)

The method of claim 1, further comprising sequencing cell free DNA from the maternal test sample to provide the sequence reads.

### Claim 12 (depends on 11)

The method of claim 11, further comprising obtaining the maternal test sample from a pregnant organism.

### Claim 13 (depends on 1)

The method of claim 1, wherein the aligning in (b) comprises using the computing apparatus to align at least about 1 million reads.

### Claim 14

A computer program product comprising a non-transitory computer readable medium on which is provided program instructions for classifying a copy number variation in a fetal genome, the program instructions comprising:
(a) code for receiving sequence reads from fetal and maternal nucleic acids in a maternal test sample, wherein the sequence reads are provided in an electronic format;
(b) code for aligning the sequence reads to one or more bins from a reference sequence using a computing apparatus and thereby providing sequence tags corresponding to the sequence reads;
(c) code for computationally identifying a number of those sequence tags that are from one or more bins by using the computing apparatus and determining that a first bin of interest in the fetus harbors a copy number variation;
(d) code for calculating a first fetal fraction value by a first method that does not use information from the tags from the first bin of interest;
(e) code for calculating a second fetal fraction value by a second method that uses information from the tags from the first bin of interest; and
(f) code for comparing the first fetal fraction value and the second fetal fraction value and using the comparison to classify the copy number variation of the first bin of interest.

### Claim 15

A system for classifying a copy number variation in a fetal genome, the system comprising:
(a) an interface for receiving at least about 10,000 sequence reads from fetal and maternal nucleic acids in a maternal test sample, wherein the sequence reads are provided in an electronic format;
(b) memory for storing, at least temporarily, a plurality of said sequence reads;
(c) a processor designed or configured with program instructions for
(i) aligning the sequence reads to one or more reference sequences and thereby providing sequence tags corresponding to the sequence reads;
(ii) identifying a number of those sequence tags that are from one or more bins of interest and determining that a first bin of interest in the fetus harbors a copy number variation;
(iii) calculating a first fetal fraction value by a first method that does not use information from the tags from the first bin of interest;
(iv) calculating a second fetal fraction value by a second method that uses information from the tags from the first bin of interest; and
(v) comparing the first fetal fraction value and the second fetal fraction value and using the comparison to classify the copy number variation of the first bin of interest.
